Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
Access Status
Fulltext not available
Authors
Chan, Arlene
Buyse, M.
Yao, B.
Date
2016Type
Journal Article
Metadata
Show full item recordCitation
Chan, A. and Buyse, M. and Yao, B. 2016. Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply. The Lancet Oncology. 17 (5): pp. e176-e177.
Source Title
The Lancet Oncology
ISSN
School
Curtin Medical School